Mr. Ryan Shean is an M.D. candidate at the Keck School of Medicine of the University of Southern California (USC). He received his B.A. Degree from Dartmouth College in 2021. His research interests include artificial intelligence in glaucoma, minimally invasive glaucoma surgeries (MIGS), and epidemiological factors involved in the pathogenesis of glaucoma.

Dr. Ning Yu received his Ph.D. Degree in Chemical and Environmental Engineering from the University of California, Riverside in 2022, and is now a Postdoctoral Scholar at Stanford University. He worked as a Research Assistant at Washington State University (2013–2015). In 2017, he moved to the University of California, Riverside, and was promoted to Graduate Mentor in 2018. His research topics mainly include Nanomaterials, Catalysis, Microscopy, and Nano-optics.

N/A

Dr. Van Nguyen is an Assistant Professor of Clinical Ophthalmology at the University of Southern California (USC). He earned a BS in Biochemistry from Louisiana State University (LSU) in Baton Rouge, LA, and an MD from LSU School of Medicine in New Orleans. He completed an ophthalmology residency at the University of Missouri and a glaucoma fellowship at USC. He has been awarded Best Paper of Session in "Inflammation, Pain, Infection" at ASCRS 2019 and Third Place in "Residents and Fellows Posters" at ASCRS 2020. His research topics include minimally invasive glaucoma surgery (MIGS) and artificial intelligence in glaucoma detection.

Dr. Ximin He is an Assistant Professor at the University of California, Los Angeles. She received her Ph.D. Degree in Chemistry, Nanoscience, and Optoelectronics from the University of Cambridge in 2010. She worked as a Research Associate at Harvard University (2010–2013). In 2014, she moved to Arizona State University and was promoted to Assistant Professor. She has been awarded the CIFAR Azrieli Global Scholar (2019–2021), the International Society of Bionic Engineering (ISBE) Outstanding Youth Award (2019), and the Hellman Fellows Award (2018). Her research topics mainly include Optical sensing of chemical and biological molecules, Bioinspired self-regulating materials, Chemo-mechanically modulated separation of metal ions and cancer cells, Novel stimuli-responsive polymers for soft robots, Photo-responsive materials for optics, photonics, waveguides, and photo-harvesting, Biomaterials for controlled cell adhesion and migration, and 3D printing technology.

N/A

Dr. Kimberly Gokoffski is an Assistant Professor of Clinical Ophthalmology and Associate Director of Research at the Institute for Technology and Medical Systems (ITEMS). She has been awarded the Mentored Career Development Award from the National Eye Institute for her research into retinal cell regeneration, the Dr. Douglas H. Johnson Award for glaucoma research from BrightFocus Foundation, and the Thomas and Susan Carlow Young Investigator Award from the North American Neuro-Ophthalmology Society. Her research topics mainly include Neuro-Ophthalmology, Optic Neuropathies, Thyroid Eye Disease, Strabismus, Orbital inflammation, Ptosis, and Cranial Nerve Palsies.

Dr. Yangzhi Zhu is an Assistant Professor at the Terasaki Institute for Biomedical Innovation (Los Angeles). He received Ph.D. degree in Chemical Engineering from the University of California, Riverside in 2019. He finished his postdoctoral training in nanoengineering at the University of California, San Diego. His group is a multidisciplinary team that bridges scientists, engineers, and clinicians and has been focused on wearable medical devices, which are boundless, ranging from digital healthcare to precision medicine.

Dr. Benjamin Xu, M.D., Ph.D. received his B.S. from Yale University and M.D. and Ph.D. in neuroscience from Columbia University. He then completed his ophthalmology residency at the LAC+USC Medical Center / USC Roski Eye Institute and glaucoma fellowship at the UCSD Shiley Eye Institute under the mentorship of Dr. Robert N. Weinreb. He is now Chief of the Glaucoma Service at the USC Roski Eye Institute. His NIH-funded research focuses on developing new diagnostic tools to detect and care for patients with glaucoma using OCT imaging and artificial intelligence (AI). He also studies the impact of glaucoma on patient populations and healthcare systems worldwide using epidemiological and electronic healthcare data and devises new strategies to deliver more efficient and effective glaucoma care.